Adderall shortage overview:
- Who: There is a shortage of the drugs Adderall and Adderall IR, the U.S. Food and Drug Administration (FDA) announced.
- Why: Drug manufacturer Teva is having ongoing intermittent manufacturing delays that have led to the shortage, the FDA says.
- Where: The Adderall shortage impacts the supply across the United States.
There is a shortage of the drugs Adderall and Adderall IR in the United States, the U.S. Food and Drug Administration (FDA) announced. The drug is a formulation of amphetamine mixed salts.
The shortage comes as drug manufacturer Teva is having ongoing intermittent manufacturing delays, the FDA said.
“Other manufacturers continue to produce amphetamine mixed salts, but there is not sufficient supply to continue to meet U.S. market demand through those producers,” the FDA said in its notice.
Adderall is most commonly used to treat both attention deficit hyperactivity disorder (ADHD) and narcolepsy, the FDA said.
Until the supply is back to normal, the FDA recommends that those who regularly take the drug consult with a health-care professional to find the best alternative treatment option. That includes the option of using the extended-release version of Adderall.
Adderall shortage comes after Aug. 1 notice of ADHD stimulant medication shortage
The Adderall shortage notification comes after the FDA issued notice on Aug. 1 that there had been an overall shortage of stimulant medications to treat ADHD.
“The FDA and DEA do not manufacture drugs and cannot require a pharmaceutical company to make a drug, make more of a drug, or change the distribution of a drug,” the FDA said then. “That said, we are working closely with numerous manufacturers, agencies, and others in the supply chain to understand, prevent, and reduce the impact of these shortages.”
Stimulant prescription medications rose 45.5% in use between 2012 and 2021, the FDA said.
During 2020 and 2021, in fact, there was a spike in prescriptions of 10% in some age groups as virtual prescribing became more common and accepted, the FDA said.
The FDA then asked that manufacturers, distributors, pharmacies and payers to work together to maintain access to stimulant medications when the drugs are appropriately prescribed.
In 2016, the manufacturer of Adderall XR agreed to pay $14.75 million to resolve allegations that the company intentionally delayed the availability of a generic version of the medication.
Are you impacted by the Adderall shortage? Let us know in the comments.
Don’t Miss Out!
Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!
Read About More Class Action Lawsuits & Class Action Settlements:
- Recall issued for sodium bicarbonate, lidocaine HCl injections due to potential glass contamination
- Batch of betaxolol tablets recalled over possible oxycodone contamination
- Family Dollar initiates recall for OTC drugs, medical devices shipped outside temp recs
- Biomic Sciences initiates recall for nasal sprays due to microbial contamination
Honda, Hyundai, Kia, Subaru vehicle data collection class action lawsuit investigation
May 17, 2024 | Legal News
17 thoughts onFDA announces Adderall shortage
I had to go without my Adderall prescription a few times between 2019-2022. I was also paying out of pocket with no insurance. I had to go to several pharmacies to find it sometimes.
I went months without Adderall and delayed waiting on meds in Idaho and had to switch to a less than adequate management of my ADHD symptoms and would like to be added
I had to switch from Adderall XR to Vyvanse at some point because of the Adderall XR shortage. Now, I can rarely get 30 Vyvanse capsules per month. The pharmacy is always running low, so I take what I can get. And still get charged the co-pay for 30 capsuoes.
Iv noticed the amp/dextro I get was keeping me alert as it used too. I got to reading on the bottle and 15 mg of generic amp/dextro is really 9.4 for the base amp. Really sucks because I can’t function like I should.
I’ve been taking my ADHD medication responsibly for 16 years. Last year I was not able to pick it up due to the shortage and I was in a car accident. It was my fault because I started daydreaming while driving and wasn’t focused on the road. It was a horrible and costly experience. It is not okay to abruptly stop taking a stimulant you’ve relied on to function for so long.
Additionally, there are major changes in the efficacy of these drugs. I have made a number of complaints to the FDA and no one seems to take it seriously. Even Teva, which was once the most reliably effective generic brand, has changed in the way it metabolizes and feels. I am not alone in feeling this and I know I’m not crazy or paranoid. As I mentioned, I’ve been taking it for most of my adult life and I know when it’s working differently. Some generics barely work at all and this is also a complaint that’s growing at an alarming rate amongst patients.
I have been on this medication for Brain Damage for many years. I cant take all compounds that are mixed with Medication to manufacture it. This shortage of Teva (The only supplier I can take and it actually turns my brain on. ) I have suffered greatly not being able to perform work duties. My day to day memory is gone. I am lost no matter where I drive. Please add me!!